7-151560611-G-C
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM2PM5PP3_StrongPP5_Moderate
The NM_016203.4(PRKAG2):c.1591C>G(p.Arg531Gly) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R531L) has been classified as Likely pathogenic.
Frequency
Consequence
NM_016203.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRKAG2 | NM_016203.4 | c.1591C>G | p.Arg531Gly | missense_variant | Exon 15 of 16 | ENST00000287878.9 | NP_057287.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Wolff-Parkinson-White syndrome, childhood-onset Pathogenic:1
- -
Cardiovascular phenotype Pathogenic:1
The p.R531G pathogenic mutation (also known as c.1591C>G), located in coding exon 15 of the PRKAG2 gene, results from a C to G substitution at nucleotide position 1591. The arginine at codon 531 is replaced by glycine, an amino acid with dissimilar properties, and is located in a cystathione beta-synthase (CBS) domain. This variant has been described in a family with multiple affected individuals showing a combination of findings, including early age of onset, syncope, Wolff-Parkinson-White (WPW) syndrome, ventricular pre-excitation, and atrial fibrillation (Gollob MH et al. Circulation, 2001 Dec;104:3030-3). Mouse models with this mutation have been show to develop WPW syndrome and cardiac hypertrophy (Yang X et al. J. Biol. Chem., 2016 Nov;291:23428-23439). An alternate amino acid substitution at this position, p.R531Q (c.1592G>A), has been detected in congenital cardiomegaly cases with increased glycogen concentrations in tissues, hypertrophic cardiomyopathy (HCM), Wolff-Parkinson-White syndrome and/or other abnormal ECG findings, including several reportedly de novo cases (Burwinkel B et al. Am. J. Hum. Genet., 2005 Jun;76:1034-49; Alfares AA et al. Genet. Med., 2015 Nov;17:880-8). Based on internal structural assessment, this alteration results in loss of specific AMP recognition interactions (Xiao B et al. Nat Commun, 2013;4:3017). Additional functional studies have demonstrated impaired AMP/ATP binding, although the exact physiological impact of this finding has not been confirmed (Scott JW et al. J. Clin. Invest., 2004 Jan;113:274-84; Burwinkel B et al. Am. J. Hum. Genet., 2005 Jun;76:1034-49). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at